2008 Publications

  • Anandacoomarasaamy A, Caterson I, Sambrook P, Fransen M, March L: The impact of obesity on the musculoskeletal system. Int J Obes. 32: 211-222, 2008.
  • Anandacoomarasamy A, Bagga H, Ding C, Burkhardt D, Sambrook PN, March LM: Predictors of clinical response to intraarticular Hylan injections – a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. J Rheumatol. Apr 35(4): 685-90, 2008.
  • Blyth FM, Rochat S, Cumming RG, Creasey H, Handelsman DJ, Le Couteur DG, Naganathan V, Sambrook PN, Seibel MJ, Waite LM: Pain, frailty and comorbidity in older men, The CHAMP Study. Pain. 140: 224-230, 2008.
  • Cake M, Read R, Edwards S, Smith MM, Burkhardt D, Schiavanato A, Little C, Ghosh P: Changes in gait after bilateral meniscectomy in sheep: effect of two hyaluronan preparations. J Orthop Science. 13: 514-523, 2008.
  • Chen JS, Hogan JC, Lyubomirsky, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporosis Int. in press, 2008.
  • Chen JS, March LM, Cumming RG, Cameron ID, Simpson JM, Lord SR, Sambrook PN: Role of quantitative ultrasound to predict fracture among institutionalised older people with a history of fracture. Osteoporosis Int. May 27. [Epub ahead of print], 2008.
  • Chen JS, Simpson JM, March LM, Cameron ID, Cumming RG, Lord SR, Seibel MJ, Sambrook PN: Risk factors for fracture following a fall among older people in residential care facilities in Australia. J Am Geriatr Soc. Nov 56(11): 2020-6, 2008.
  • Chen JS, Simpson JM, March LM, Cameron ID, Cumming RG, Lord SR, Seibel MJ, Sambrook PN: Fracture risk assessment in frail older people using clinical risk factors. Age Ageing. Sep 37(5): 536-41, 2008.
  • Combe B, C. Codreanu, U. Fiocco, M. Gaubitz, P. P. Geusens, T. K. Kvien, K. Pavelka, P. N. Sambrook, J. S. Smolen, R. Khandker, A. Singh, J. Wajdula, Fatenejad S: Efficacy, safety, and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double blind study. Ann Rheum Dis. in press, 2008.
  • Cranney A, Wells GA, Yestisir L, Adami C, Cooper C, Delmas P, Miller P, Papadoulos, Reginster JY, Sambrook P, Silverman P, Siris E, Adachi R: Ibandronate for the prevention of non-vertebral fractures: a pooled analysis of individual patient data. Osteoporosis Int. in press, 2008.
  • Delbaere K, Close JC, Menz HB, Cumming RG, Cameron ID, Sambrook PN, March LM, Lord SR: Development and validation of fall risk screening tools for use in residential aged care facilities. Med J Aust. Aug 18 189(4): 193-6, 2008.
  • Fitzgerald J, Rich C, Burkhardt D, Allen J, Herzka AS, Little CB: Evidence for articular cartilage regeneration in MRL/MpJ mice. Osteoarthritis Cartilage. 16: 1319-26, 2008.
  • Fosang AJ and Little CB: Aggrecans and aggrecanases are targets in osteoarthritis. Nat Clin Pract Rheumatol. 4: 420-7, 2008.
  • Fosang AJ, Last K, Stanton H, Golub SB, Little CB, Jackson DC, Brown L: Neoepitope Antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. In Matrix Metalloproteinase Protocols (2nd Ed), Humana Press 2008 (submitted Feb 2008).
  • Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag K, Lane NE, Hochberg MC: Drug insight: choosing a drug treatement strategy for women with osteoporosis – an evidence based clinical perspective. Nat Clin Pract Rheumatol. 4: 240-248, 2008.
  • Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, Dieppe P: Development and Preliminary Psychometric Testing of a New OA Pain Measure - An OARSI/OMERACT Initiative. Osteoarthritis Cartilage. Apr 16(4): 409-14, 2008.
  • Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R: Understanding the Pain Experience in Hip and Knee Osteoarthritis – An OARSI/OMERACT Initiative. Osteoarthritis Cartilage. Apr 16(4): 415-22, 2008.
  • Jackson C and Xue M: Activated protein C – an anticoagulant that does more than stop clots. Int J Biochem Cell Biol. 40(12): 2692-7, 2008.
  • Jackson C, Whitmont K, Tritton S, March L, Sambrook P, Xue M: New therapeutic applications for the anticoagulant, activated protein C. Expert Opin Biol Ther. Aug 8(8): 1109-22, 2008.
  • Jackson M, Smith MM, Smith SM, Xue M, Jackson C, Little CB: The role of activated protein C (APC) in MMP activation and collagenolysis in cartilage. Arthritis Rheum. In Press Nov 2008.
  • Jackson Miriam, Smith Margaret, Xue Meilang, Jackson Chris, Little Chris: Activation of Cartilage Matrix Metalloproteinases by Activated Protein C. Arthr Rheum. in press
  • Little CB and Smith MM: Animal models of osteoarthritis. Current Rheumatology Reviews 4: 175-182, 2008.
  • March L: A fluoroscopic-guided intraarticular corticosteroid injection improved pain in osteoarthritis of the hip. ACP J Club. Jan-Feb 148(1): 13, 2008.
  • March LM, Barcenilla AL, Cross MJ, Lapsley HM, Parker D, Brooks PM: Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin Rheumatol. May 24. [Epub ahead of print], 2008.
  • Melrose J, Burkhardt D, Smith SM, Read R, Cake M, Taylor TKF, Dillon C, Little CB: Calcification in the ovine intervertebral disc: a model of hydroxyapatite deposition disease. Eur Spine J. Accepted Dec 23 2008.
  • Melrose J, Fuller ES, Roughley PJ, Smith MM, Kerr B, Hughes CE, Caterson B, Little CB: Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues. Arthritis Res Ther. Jul 14,10: R79, 2008
  • Melrose J, Hayes AJ, Whitelock JM, Little CB: Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues. Bioessays. 30: 457-69, 2008.
  • Melrose J, Smith SM, Appleyard RC, Little CB: Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur Spine J. 17: 314-24, 2008.
  • Melrose J, Smith SM, Little CB, Moore R, Vernon-Roberts B, Fraser R: Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies. Eur Spine J. 17: 1131-1148, 2008
  • Melrose J, Smith SM, Smith MM, Little CB: The use of Histochoice a non-cross-linking fixative in the histological examination of the intervertebral disc, meniscus, articular and growth plate cartilages. Biotech Histochem. Feb, 83(1): 47-53, 2008.
  • Sambrook PN, Ebeling P: Osteonecrosis of the jaw. Curr Rheum Rep. 10: 97-101, 2008.
  • Sambrook PN: Glucocorticoid induced osteoporosis. Rheumatology, 4th Edn, Chapter 191, Mosby, editors Hochberg MC, Silman AJ, Smolen J, Weinblatt ME, Weisman MH, 2008.
  • Sambrook, PN: Glucocorticoid osteoporosis. Int J Rheum Dis. 11: 381-385, 2008.
  • Smith MM, Cake MA, Ghosh P, Schiavinato A, Read RA, Little CB: Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology (Oxford). 47: 1172-8, 2008.
  • Smith MM, Sakarai G, Smith SM, Young AA, Melrose J, Stewart C, Appleyard RC, Peterson JL, Gillies M, Dart A, Sonnabend DH, Little CB: Modulation of aggrecan and ADAMTS expression in endon pathology induced by altered strain. Arthritis Rheum. 58: 1055-66, 2008
  • Whitmont K, Reid I, Tritton S, March L, Xue M, Lee M, Fulcher G, Sambrook P, Slobedman E, Cooper A, Jackson C: Treatment of chronic leg ulcers with topical activated protein C. Arch Dermatol. Nov 144(11): 1479-83, 2008
  • Wilson R, Belluoccio D, Little CB, Fosang AJ, Bateman JF: Proteomic characterization of cartilage degradation in vitro. Arthritis Rheum. 58: 3120-31, 2008.
  • Xie L, Galettis A, Morris J, Jackson C, Twigg SM, Gallery ED: Intercellular adhesion molecule-1 (ICAM-1) is required for monocyte adhesion to the placental bed endothelium in diabetic human pregnancy. Diabetes Metab Res Rev. May-Jun, 24(4): 294-300, 2008.
  • Xue A, Scarlett C, Jackson CJ and Smith R: Diagnostic and prognostic significance of uPAR and PAI-2 in pancreatic ductal adenocarcinoma using multigene assay. Pancreas. 36:160-167, 2008.
  • Xue Aiqun, Xue Meilang, Jackson Christopher and Smith Ross C: Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol. in press.
  • Xue M, Jackson CJ: Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes. J Invest Dermatol. Nov 128(11): 2676-85, 2008.
  • Xue M, Smith M, Little C, Sambrook P, March L, Jackson CJ: Activated protein C mediates a healing phenotype in cultured tenocytes. J Cell Mol Med. May 2 [Epub ahead of print], 2008.